在治疗耐药性抑郁症中,通过迷走神经依赖的肠道微生物群-大脑轴的神经炎症
1Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
神经炎症与严重抑郁症 (MDD) 有关. 通过迷走神经准肠道微生物群-大脑轴显示出治疗耐治疗抑郁症 (TRD) 的希望.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
背景情况:
- 神经炎症与主要抑郁症 (MDD) 和耐治疗抑郁症 (TRD) 有关.
- 升高的炎症生物标志物区分了TRD患者与抗抑郁药响应者.
- 肠道-微生物群-大脑轴,特别是迷走神经,是抑郁症中神经炎症的关键媒介.
研究的目的:
- 审查迷走神经依赖性肠道微生物群-大脑轴在抑郁症中的作用,包括TRD.
- 讨论针对这一轴的TRD潜在的治疗策略.
主要方法:
- 在抑郁症模型中对便微生物群移植 (FMT) 的临床前和临床数据的审查.
- 检查膜下阴道切除术对类似抑郁症的行为和炎症的影响.
- 在抑郁症模型中分析 (R) - 胺 (阿基他胺) 对肠道微生物群组成的影响.
主要成果:
- 抑郁症患者的FMT诱导了类似抑郁症的行为和动物的全身炎症.
- 腹膜下阴道切除术消除了FMT诱导的类似抑郁症的表型和炎症.
- 瓦古托米也阻断了血清激素药物的抗抑郁作用.
- (R) 胺可以恢复肠道微生物群,并产生抗抑郁作用.
结论:
- 迷走神经依赖的肠道微生物群-大脑轴在抑郁症的发病过程中至关重要.
- 便微生物种移植,迷走神经刺激和阿基坦胺是TRD潜在的新疗法.
更多相关视频
07:49Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Physiology of Enteric Nervous System and Gut Health
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
